VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ERIC 2022 | Key challenges in developing CAR-T therapy for CLL

Marco Ruella, MD, University of Pennsylvania, Philadelphia, PA, highlights the major obstacles to developing CAR-T for patients with chronic lymphocytic leukemia (CLL), including T cell immune dysfunction, and the highly immunosuppressive microenvironment present in these patients. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter